Viking Therapeutics stock crashes after weight-loss pill trial shows high dropout rate
Viking Therapeutics (VKTX) stock crashed more than 40% on Tuesday after a phase 2 trial of its weight-loss pill showed a high patient dropout rate. The company stated that most of the adverse treatment-related symptoms were gastrointestinal in nature, and 99% of the adverse events were mild. Over half (58%) of participants taking the drug…